-
Add to Cart The item has been addedAb182813-100μgLirentelimab (anti-Siglec-8) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). Lirentelimab (anti-Siglec-8) induces cell apoptosis of IL-5-activated eosinophils and inhibits IgE-mediated mast cell -
Add to Cart The item has been addedAb182813-10mgLirentelimab (anti-Siglec-8) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). Lirentelimab (anti-Siglec-8) induces cell apoptosis of IL-5-activated eosinophils and inhibits IgE-mediated mast cell -
Add to Cart The item has been addedAb182813-1mgLirentelimab (anti-Siglec-8) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). Lirentelimab (anti-Siglec-8) induces cell apoptosis of IL-5-activated eosinophils and inhibits IgE-mediated mast cell -
Add to Cart The item has been addedAb182813-5mgLirentelimab (anti-Siglec-8) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). Lirentelimab (anti-Siglec-8) induces cell apoptosis of IL-5-activated eosinophils and inhibits IgE-mediated mast cell -
Add to Cart The item has been added634-401-044Llama IgG2 Antibody 0.5mg
Price: $329.71List Price: $366.34Antibody Anti-Llama IgG2 is suitable for immunoblotting (western or dot blot), ELISA, and immunohistochemistry assays requiring lot-to-lot consistency. -
Add to Cart The item has been addedAb182786-1mgLoncastuximab (anti-CD19) is an anti-CD19 monoclonal antibody. Loncastuximab (anti-CD19) shows antitumor activity and has potential application in non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL).Purity>:95% -
Add to Cart The item has been added7393LPIN1 Antibody, 100 ug UN1687
Price: $623.39List Price: $692.66HOST SPECIES: Rabbit CLONALITY: Polyclonal TESTED APPLICATIONS: E, WB, IHC-P, IF APPLICATIONS: LPIN1 antibody can be used for detection of LPIN1 by Western blot at 1 - 2 μg/mL. Antibody validated: Western Blot in human samples -
Add to Cart The item has been addedAb175588-100μgLutikizumab (anti-IL1a &: IL1b) is an anti-IL-1α and IL-1β dual variable domain immunoglobulin. Lutikizumab (anti-IL1a &: IL1b) binds and inhibits IL-1α and IL-1β. Lutikizumab (anti-IL1a &: IL1b) can be used for the research of -
Add to Cart The item has been addedAb175588-10mgLutikizumab (anti-IL1a &: IL1b) is an anti-IL-1α and IL-1β dual variable domain immunoglobulin. Lutikizumab (anti-IL1a &: IL1b) binds and inhibits IL-1α and IL-1β. Lutikizumab (anti-IL1a &: IL1b) can be used for the research of -
Add to Cart The item has been addedAb177860-100μgLY3022859 (anti-TGFBR2) is a monoclonal antibody directed against transforming growth factor-beta receptor type II (TGF-beta RII) with potential antineoplastic activity. -
Add to Cart The item has been addedAb177860-10mgLY3022859 (anti-TGFBR2) is a monoclonal antibody directed against transforming growth factor-beta receptor type II (TGF-beta RII) with potential antineoplastic activity. -
Add to Cart The item has been addedAb177860-1mgLY3022859 (anti-TGFBR2) is a monoclonal antibody directed against transforming growth factor-beta receptor type II (TGF-beta RII) with potential antineoplastic activity.
